We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Materna Medical Stock

Invest in or calculate the value of your shares in Materna Medical or other pre-IPO companies through EquityZen's platform.

Get Started

Materna Medical Stock (MAME)

Materna is a medical device company focused on preserving and recovering women's pelvic health.

About Materna Medical Stock

Founded

2007

Headquarters

Mountain View, CA, US

Industries

Software, Data and Analytics, Artificial Intelligence

Materna Medical is a medical device company focused on preserving and maintaining women's pelvic health. In 2018, our team launched Milli, the first expanding vaginal dilator to address pelvic pain in the general population. In addition, we are conducting a clinical trial for Materna Prep, a device to be used during the first stage of labor to expedite delivery and reduce the incidence of internal damage to the mother's pelvic region. Materna's birth device provides significant health benefits to patients, saves physicians time, can shorten the length of delivery, and will save money for the healthcare system by reducing the incidence of damage to the pelvic anatomy. Also, over 20 million women suffer from pelvic pain and cannot comfortably have intercourse; Milli is the most gentle vaginal dilator available and is preferred by over 90% of women to the current static, graduated dilator sets that the current standard of care.

Materna Medical Management

Leadership team at Materna Medical

CEO and President

Tracy MacNeal

Co-Founder and Lead Designer

Michael Stewart

Locked Features

Join now and verify your accreditation status to gain access to:

  • Materna Medical current valuation
  • Materna Medical stock price
  • Available deals in Materna Medical and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Materna Medical stock?

Accredited investors can buy pre-IPO stock in companies like Materna Medical through EquityZen funds. These investments are made available by existing Materna Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Materna Medical stock?

Shareholders can sell their Materna Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."